Fractional CO2 Laser Fenestration and Steroid Delivery in HS Lesions
Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
Assess the efficacy of fractional ablative CO2 therapy combined with topical steroids in HS
patients with Hurley stage I or stage II disease.
Hidradenitis suppurativa (HS) is a chronic, oftentimes debilitating inflammatory skin
condition that presents with painful lesions in intertriginous areas of the body. The
reported prevalence of HS in the U.S. is around 1-4%. Medical therapies, which typically
consist of topical or systemic antibiotics, hormone- regulating drugs, and immunomodulators,
are initially used to control the disease but HS can be recalcitrant to these modalities in
the long-term. Optimizing management of mild-moderate HS is crucial to prevent disease
progression and improve patients' quality of life.